Psychiatric Medication Users by Age and Sex in the United States, 1999–2018

References

1. 1.↵
   1. Moore TJ,
   2. Mattison DR

   . Adult utilization of psychiatric drugs and differences by sex, age, and race. JAMA Intern Med 2017;177:274–5.

   OpenUrl
2. 2.↵
   1. Paulose-Ram R,
   2. Safran MA,
   3. Jonas BS,
   4. Gu Q,
   5. Orwig D

   . Trends in psychotropic medication use among U.S. adults. Pharmacoepidem Drug Safe 2007;16:560–70.

   OpenUrl
3. 3.↵
   1. Paulose-Ram R,
   2. Jonas BS,
   3. Orwig D,
   4. Safran MA

   . Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988–1994. J Clin Epidemiol 2004;57:309–17.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Brody DJ,
   2. Gu Q

   . Antidepressant use among adults: United States, 2015–2018. NCHS Data Brief, no. 377. Hyattsville, MD: National Center for Health Statistics. 2020.
5. 5.↵
   1. Olfson M,
   2. King M,
   3. Schoenbaum M

   . Antipsychotic treatment of adults in the United States. J Clin Psychiatry 2015;76:1346–53.

   OpenUrlPubMed
6. 6.↵
   1. Johansen ME,
   2. Niforatos JD

   . Benzodiazepine use in the USA is driven by long-term users: a repeated cross-sectional study of MEPS 2002–2016. J Gen Intern Med 2019;34:2717–9.

   OpenUrl
7. 7.↵
   1. Jonas BS,
   2. Gu Q,
   3. Albertorio-Diaz JR

   . Psychotropic medication use among adolescents: United States, 2005–2010. NCHS Data Brief, no. 135. Hyattsville, MD: National Center for Health Statistics. 2013.
8. 8.↵
   1. Olfson M,
   2. King M,
   3. Schoenbaum M

   . Stimulant treatment of young people in the United States. J Child Adolesc Psychopharmacol 2016;26:520–6.

   OpenUrl
9. 9.↵
   Medical Expenditure Panel Survey. MEPS HC-209: 2018 Consolidated Data File. https://meps.ahrq.gov/data_stats/download_data/pufs/h209/h209doc.pdf. Accessed October 12, 2020.
10. 10.↵
    American Psychiatric Association; Choosing Wisely. https://www.choosingwisely.org/clinician-lists/american-psychiatric-association-antipsychotics-in-children-or-adolescents/. Accessed October 12, 2020.
11. 11.↵
    1. Cipriani A,
    2. Zhou X,
    3. Del Giovane C,
    4. et al

    . Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 2016;388:881–90.

    OpenUrlPubMed
12. 12.↵
    1. Cipriani A,
    2. Furukawa TA,
    3. Salanti G,
    4. et al

    . Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018;391:1357–66.

    OpenUrlPubMed
13. 13.↵
    1. Huhn M,
    2. Nikolakopoulou A,
    3. Schneider-Thoma J,
    4. et al

    . Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis [published correction appears in Lancet. 2019 Sep 14;394(10202):918. Lancet 2019;394:939–51.

    OpenUrlPubMed
14. 14.↵
    1. Holbrook AM,
    2. Crowther R,
    3. Lotter A,
    4. Cheng C,
    5. King D

    . Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000;162:225–33.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Butler M,
    2. Urosevic S,
    3. Desai P,
    4. et al

    . Treatment for Bipolar Disorder in Adults: A Systematic Review. Comparative Effectiveness Review No. 208. (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-2012-00016-I.) AHRQ Publication No. 18-EHC012-EF. Rockville, MD: Agency for Healthcare Research and Quality; August 2018.
16. 16.↵
    Medical Expenditure Panel Survey. MEPS HC-206A: 2018 Prescribed Medicines https://meps.ahrq.gov/data_stats/download_data/pufs/h206a/h206adoc.pdf. Accessed October 11, 2020.
17. 17.↵
    1. Hill SC,
    2. Zuvekas SH,
    3. Zodet MW

    . Implications of the accuracy of MEPS prescription drug data for health services research. Inquiry 2011;48:242–59.

    OpenUrlPubMed
18. 18.↵
    1. Kessing LV,
    2. Vradi E,
    3. Andersen PK

    . Life expectancy in bipolar disorder. Bipolar Disord 2015;17:543–8.

    OpenUrlCrossRef
19. 19.↵
    1. Crump C,
    2. Sundquist K,
    3. Winkleby MA,
    4. Sundquist J

    . Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry 2013;70:931–9.

    OpenUrl
20. 20.↵
    1. Gale CR,
    2. Batty GD,
    3. Osborn DPJ,
    4. Tynelius P,
    5. Whitley E,
    6. Rasmussen F

    . Association of mental disorders in early adulthood and later psychiatric hospital admissions and mortality in a cohort study of more than 1 million men. Arch Gen Psychiatry 2012;69:823–31.

    OpenUrlCrossRefPubMedWeb of Science